Privately-held Alchemab Therapeutics, a biotech that uses the power of human immune evolution to identify and develop ...

Vertex Pharmaceuticals missed Wall Street estimates for the first quarter of 2025, as sales of its cystic fibrosis (CF) ...

US healthcare giant Johnson & Johnson has presented data from its Phase III LUMEOS study and disclosed that the trial did not ...

US pharma major Bristol Myers Squibb (NYSE: BMY) is set to lay off another 516 employees at its New Jersey, USA site, ...

US investment firm Deerfield Management has closed its latest fund with $600 million in commitments to support advances in ...

Some $45 million has been raised in a Series B financing round by Nuevocor, an IND-stage biotech developing therapies for ...

UK pharma major AstraZeneca (LSE: AZN) today revealed that its Calquence (acalabrutinib) in combination with bendamustine and ...

Benchtop cell factory company Astraveus has entered into a strategic partnership with The Netherlands Center for the Clinical ...

Portugal-based Hovione and Firstgene Life Sciences, a portfolio company of the Swiss incubator Xlife Sciences (SIX: XLS), ...

Priothera today announced the appointment of Jens Hasskarl, as its chief medical officer (CMO). Founded in France and ...

The US Food and Drug Administration (FDA) accepted Novo Nordisk’s New Drug Application (NDA) submission for an ...

USA-based rare disease drug developer PTC Therapeutics (Nasdaq: PTCT) on Monday announced results from the Phase II PIVOT-HD ...